MENU

Statement of the DDB on the change of leadership in the Philippine Drug Enforcement Agency

The Dangerous Drugs Board welcomes the assumption of new PDEA Director General Wilkins Villanueva after Malacañang released his appointment signed last 22 May 2020. Incoming DG Villanueva has been a steadfast partner of DDB even during his early years as career officer of PDEA. DDB has involved him in many of its anti-drug efforts particularly in policy formulation and strategy development aspects which helped craft many of its inter-agency priorities all these years. Recognizing him as the 7th Director-General of PDEA, DDB intends to engage more closely and deepen the collaboration with his leadership noting that he will become an Ex-Officio Member of the Board.

Read more ...

DDB Eases the Use of Prescription Forms for Dangerous Drugs

The Dangerous Drugs Board now allows the use of ordinary prescription for medical preparations containing dangerous drugs.

Read more ...

DDB advocates for the use of electronic prescription for dangerous drugs medication

The Dangerous Drugs Board appeals to doctors, pharmacists, and drug store personnel to consider the use of electronic prescription for medicines included in the list of dangerous drugs as the whole country is under a State of Calamity due to the COVID-19 pandemic.

Read more ...

DDB, SDA Church hold program to update health directors on the Philippine Anti-Illegal Drugs Strategy (PADS) and board regulations

The Dangerous Drugs Board, in collaboration with the Southern Asia-Pacific Division of the Seventh-Day Adventist Church, convenes Luzon-based health directors of the religious group to update them on the Philippine Anti-Illegal Drugs Strategy (PADS) and relevant DDB regulations.

Read more ...

DDB clarifies: CBD is not cannabis per se

The Dangerous Drugs Board would like to clarify that marijuana use remains illegal in the country for both recreational and medical use. The use of Cannabidiol, however, is being considered to be allowed for treatment of certain rare forms of epilepsy like Lennox-Gastaut and Dravet Syndrome.

Read more ...

DDB, DOST-FNRI launch dietary manuals for Persons Who Use Drugs (PWUDs)

The Dangerous Drugs Board and the Department of Science and Technology-Food and Nutrition Research Institute, officially launch three dietary manuals to be used in Treatment and Rehabilitation Centers (TRCs) in the Philippines.

Read more ...

DDB, DOST-FNRI to launch dietary manuals for Persons Who Use Drugs (PWUDs)

The Dangerous Drugs Board and the Department of Science and Technology-Food and Nutrition Research Institute, will officially launch three dietary manuals to be used in Treatment and Rehabilitation Centers (TRCs) in the Philippines.

Read more ...

PRRD reappoints Cuy as Chairperson of DDB

Secretary Catalino S. Cuy was given a fresh mandate as the Chairperson of the Dangerous Drugs Board (DDB).

This was confirmed after President Rodrigo Duterte signed his reappointment papers on 21 January 2020. Secretary Cuy was first appointed at the DDB in January 2018 serving the remainder of the term of his predecessor.

Read more ...

DDB’s response to the recommendations of the Vice President on the campaign against illegal drugs

The Dangerous Drugs Board notes the recommendations of Vice President Leni Robredo on the anti-drug campaign. The agency keeps in mind the ultimate goal of establishing drug-free communities as a serious commitment of the Duterte Administration.

Read more ...

National Household Survey in the High-Risk regions of the Country

The survey determined the nature and extent of drug abuse in selected high-risk regions of the Philippines namely, the National Capital Region (NCR), Region 3, 4 and 7. Identification of drug affected barangays was undertaken in coordination with law enforcement agencies while data gathering activities were done in collaboration with the Local Government Units (LGUs) in the survey regions/areas.

A total of 12,431 persons belonging to the 10-44 age bracket representing 4, 144
households served as respondents of the survey.

Results revealed high risk groups to be workers, students, self employed, and out-ofschool youth.

A Study on the Quantity of Shabu Consumption of Selected Clients in Four (4) Selected Government Residential Centers in the Philippines

This study determined the quantity or amount of Shabu being consumed by regular users prior to their admission to the rehabilitation centers. Specifically, it ascertained the amount or quantity of Shabu consumed by selected regular users in four (4) selected government rehabilitation centers – CUREDD in Bicutan, Taguig and Cebu, the NBI TRC in Tagaytay and the Central Luzon Drug Rehabilitation Center (CLDRC) in Magalang, Pampanga. Respondents were asked on their frequency of use per month; usual or regular quantity consumed per month in grams, and the average amount of shabu consumed per month in grams.

A total of 2,179 regular users of Shabu confined in the study sites served as respondents. Asked on the frequency of drug use, 46.9% of the respondents admitted to have used Shabu 3 to 5 times a week, 30.1% daily and 14% used it 2 to 5 times a week.

As for the quantity of Shabu consumed per month in grams, 41.4% of the total respondents admitted to have consumed 4 grams or less of shabu per month and 23.2% from 5 to 9 grams.

Results further revealed that the minimum quantity consumed in grams per month is .3 grams as admitted by 3% of the respondents while the maximum consumption per month is 105 grams, as consumed by 0.1% of the respondents. The usual amount consumed per month was 4 grams and the average was 8.5 grams.

It was recommended that drug abuse prevention workers be encouraged to focus their efforts not only on the prevention of new cases but also on the formulation and development of programs/projects geared towards relapse prevention.